Below chart show the patent oppositions filing trends at the EPO in the last 12 months. The data is updated weekly and includes the number of oppositions filed by companies against the patents.
Recent patent oppositions filed at the EPO, providing crucial intelligence for R&D strategies, competitive analysis, and litigation planning. The data is updated on a weekly basis to ensure you have access to the most current information.
| Patent Number | Title | Applicant | Opposition Date | Opposition Name |
|---|---|---|---|---|
Get alerts for new patent oppositions | ||||
| Fastening Element Made Of Wood And/Or Wooden Materials | BAUSSMANN COLLATED FASTENERS | Aug 5, 2025 | RAIMUND BECK NAGELTECHNIK | |
| Methods For Improving Safety Of Blood-Brain Barrier Transport | F HOFFMANN LA ROCHE | Jul 30, 2025 | ZWICKER SCHNAPPAUF & PARTNER + 1 more opposition | |
| New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) | NOVARTIS | Jul 23, 2025 | ALFRED E TIEFENBACHER + 16 more oppositions | |
| New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) | NOVARTIS | Jul 23, 2025 | BETAPHARM ARZNEIMITTEL + 16 more oppositions | |
| New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) | NOVARTIS | Jul 23, 2025 | HAMM & WITTKOPP + 16 more oppositions | |
| New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) | NOVARTIS | Jul 23, 2025 | KRKA + 16 more oppositions | |
| New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) | NOVARTIS | Jul 23, 2025 | LANYON OPPOSITIONS + 16 more oppositions | |
| New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) | NOVARTIS | Jul 23, 2025 | POLPHARMA + 16 more oppositions | |
| New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) | NOVARTIS | Jul 23, 2025 | WUESTHOFF & WUESTHOFF + 16 more oppositions | |
| Novel Lipids And Compositions For The Delivery Of Therapeutics | ARBUTUS BIOPHARMA | Jul 23, 2025 | ARROWHOUSE + 3 more oppositions | |
| Novel Lipids And Compositions For The Delivery Of Therapeutics | ARBUTUS BIOPHARMA | Jul 23, 2025 | KELTIE + 3 more oppositions | |
| Novel Lipids And Compositions For The Delivery Of Therapeutics | ARBUTUS BIOPHARMA | Jul 23, 2025 | MERCK SHARP & DOHME UK + 3 more oppositions | |
| Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna | GLAXOSMITHKLINE | Jul 23, 2025 | ARROWHOUSE + 4 more oppositions | |
| New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) | NOVARTIS | Jul 22, 2025 | BULLE DR + 16 more oppositions | |
| New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) | NOVARTIS | Jul 22, 2025 | DEVA HOLDING + 16 more oppositions | |
| New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) | NOVARTIS | Jul 22, 2025 | TEVA PHARMACEUTICALS + 16 more oppositions | |
| Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna | GLAXOSMITHKLINE | Jul 22, 2025 | BIONTECH + 4 more oppositions | |
| Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna | GLAXOSMITHKLINE | Jul 22, 2025 | SANOFI + 4 more oppositions | |
| Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna | GLAXOSMITHKLINE | Jul 22, 2025 | WEICKMANN & WEICKMANN + 4 more oppositions | |
| New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) | NOVARTIS | Jul 21, 2025 | CAMULON + 16 more oppositions |